Qatari German Company for Medical Devices (Q.P.S.C.) (QGMD) Earnings Call Transcript & Summary

May 4, 2025

Qatar Stock Exchange QA Health Care Health Care Equipment and Supplies earnings 4 min

Earnings Call Speaker Segments

Operator

operator
#1

Hello and welcome to Qatar German Medical Devices (sic) [ Qatari German for Medical Devices ]. Please note that this call is being recorded. [Operator Instructions] Thank you. I'd like to hand over the call to our moderator, Roy Thomas. Please go ahead.

Roy Thomas

analyst
#2

Thanks, Gail. Hello, everyone. This is Roy Thomas from QNB Financial Services. I want to welcome everyone to Qatari German Medical Devices Company's First Quarter 2025 Financial Results Conference Call. On this call, from Qatari German Medical Devices Company, we have Amer Abu Shaikha, the Chief Executive Officer. We will conduct this conference call with Amer, first, reviewing the company's results; followed by Q&A. I will turn the call now over to Amer. Go ahead.

Amer Tahseen Abu Shaikha

executive
#3

Hello, everybody. This is Amer Abu Shaikha speaking, the CEO of Qatari German medical -- for Medical Devices. I'm going to give you an update about our P&L figures for Q1 2025. We get, we got revenue of QAR 4.1 million during Q1, with operating costs of [ 880 ]. This is giving us a gross profit of QAR 238,000. Actually the gross margin -- or the gross profit is a little bit decreased this quarter due to increasing the revenue of the trading division more than the manufacturing. We have won actually different tenders for manufacturing, which will be reflected in Q2, so hopefully, the figures in Q2, our margin will be more -- higher. We have other income of QAR 644,000, with selling and distribution expenses, QAR 37,000. We have incurred G&A expenses QAR 1.1 million this quarter. And you can notice that, comparing with March 2024, our G&A expenses has been decreased with a higher percentage. We have depreciation and amortization [ 1.1 ]. Again it has been decreased, comparing with the last quarter. We got a net loss QAR 1.3 million. Adding to that the finance cost, QAR 196,000, and this is giving us a net loss for the period of QAR 1.5 million for the Q1 2025. We are aiming to improve our figures in Q2 and Q3. Hopefully, by end of Q3, we will be in a profit because there are different projects we are working on. One of them is the expansion outside of Qatar, in higher range of different countries, so hopefully, our figures will be looking much better in the coming 2 quarters. Well, this is the update from my side, for Q1. If there is any specific question, I'm ready to answer.

Operator

operator
#4

[Operator Instructions] As we see no hands being raised for any questions, I would like to turn the call back to our moderator for the closing remarks. Thank you.

Roy Thomas

analyst
#5

If there are no questions, we would like to thank Amer Abu Shaikha for the results update. And we look forward to speaking to you all for the Second Quarter 2025 Results Conference Call. Thank you.

Amer Tahseen Abu Shaikha

executive
#6

Thank you very much, Roy. Thank you, guys.

Operator

operator
#7

Thank you, all, ladies and gentlemen. That concludes today's call. You may now all disconnect. Have a nice day ahead, everyone.

For developers and AI pipelines

Programmatic access to Qatari German Company for Medical Devices (Q.P.S.C.) earnings transcripts and 32,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.